Federal «register of viral hepatitis patients» – a universal tool For multifactorial epidemiological analysis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. Analysis of the epidemiological anamnesis of patients according to the Federal «Register of Patients with Viral Hepatitis» of the Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being.

Materials and methods. Information on 54,998 patients with various forms of hepatitis B was assessed, taking into account life history and information on parenteral interventions for 6 months. before the onset of the disease.

Results. Most often, patients indicated medical manipulations in medical institutions (811.7‰) and manipulations outside them (453.9‰) over 6 months. before the onset of the disease. As the most likely variant of infection, patients noted sexual contact (65.8‰), medical procedures in a hospital setting (63.0‰), manipulations in outpatient clinics (59.3‰) and intravenous drug use (33.2‰).

Conclusion. The «Register» is an important tool for tracking monitoring parameters of the epidemiological surveillance system, as well as assessing the effectiveness of preventive measures. It is a source of information that ensures scientifically based adoption of organizational and management decisions in the field of prevention of viral hepatitis.

全文:

受限制的访问

作者简介

Elena Kudryavtceva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: kudryavtseva@cmd.su
ORCID iD: 0000-0002-7325-8577

MD., Leading Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Marina Korabel’nikova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: korabelnikova@cmd.su
ORCID iD: 0000-0002-2575-8569

Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Yarina Panasyuk

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: epidbsmp@mail.ru
ORCID iD: 0000-0002-9335-4953

Epidemiologist, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Nadezhda Churilova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: churilova@cmd.ru
ORCID iD: 0000-0001-5344-5829

Junior Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Natalia Vlasenko

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: vlasenko@cmd.su
ORCID iD: 0000-0002-2388-1483

Researcher, Laboratory of viral hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Dmitry Dubodelov

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: dubodelov@cmd.su
ORCID iD: 0000-0003-3093-5731

Cand. Med. Sci., Senior Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Vitalina Klushkina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: klishkina@cmd.su
ORCID iD: 0000-0001-8311-8204

Cand. Med. Sci., Senior Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Vasily Zavolozhin

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

编辑信件的主要联系方式.
Email: Zavolozhin@cmd.su
ORCID iD: 0000-0003-4015-1105

Junior Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Zinaida Rodionova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: rodionova.z@cmd.su
ORCID iD: 0000-0003-0401-279X

Consultant, Organizational and Methodological Department

俄罗斯联邦, Moscow

Anton Laptev

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: alaptev@cmd.su
ORCID iD: 0000-0001-8819-0205

Specialist of Information and Analytical Technical Support Service, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Tatiana Semenenko

N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia

Email: semenenko@gamaleya.org
ORCID iD: 0000-0002-6686-9011

MD, Professor, Head, Epidemiology Department

俄罗斯联邦, Moscow

Stanislav Kuzin

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: drkuzin@list.ru
ORCID iD: 0000-0002-0616-9777

MD, Professor, Head, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

俄罗斯联邦, Moscow

Vasily Akimkin

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: vgakimkin@yandex.ru
ORCID iD: 0000-0003-4228-9044

Academician of the Russian Academy of Sciences, MD. Professor, Director

俄罗斯联邦, Moscow

参考

  1. Иванов А.В. Регистры как основа для сбора данных и построения доказательств. Реальная клиническая практика: данные и доказательства 2021; 1(1): 10–5. https://doi.org/10.37489/2782-3784-myrwd-3
  2. Ivanov A.V. [Registers as a basis for data collection and evidence building]. Real-World Data & Evidence 2021; 1(1): 10–5. (In Russ.). https://doi.org/10.37489/2782-3784-myrwd-3
  3. Ягудина Р.И., Литвиненко М.М., Сороковиков И.В. Регистры пациентов: структура, функции, возможности использования. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология 2011; 4(4): 3–7.
  4. Yagudina R.I., Litvinenko M.M., Sorokovikov A.V. [Patient registers: structure, functions, possibilities of use]. Pharmacoeconomic. Modern Pharmacoeconomics and Pharmacoepidemiology 2011; 4(4): 3–7. (In Russ.).
  5. Schleelein L.E., Harris K.A., Elliott E.M. Developing Multicenter Registries to Advance Quality Science. Anesthesiol. Clin. 2018; 36(1): 75–86. doi: 10.1016/j.anclin.2017.10.002
  6. EMA. Patient registries. https://www.ema.europa.eu/en/human-regulatory/postauthorisation/patient-registries
  7. Покровский В.И., Тотолян А.А. (ред.). Вирусные гепатиты в Российской Федерации. Аналитический обзор. 11 выпуск. СПб.: ФБУН НИИЭМ имени Пастера, 2018. 112 с.
  8. Pokrovsky V.I., Totolyan A.A. (eds.). [Viral hepatitis in the Russian Federation. Analytical review]. 11 issue. St. Petersburg: Pasteur Research Institute, 2018. 112 p. (In Russ.).
  9. ВОЗ: Гепатит В. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
  10. [WHO: Hepatitis B]. (In Russ.). https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
  11. Schweitzer A., Horn J., Mikolajczuk R.T., Krause G., Ott J.J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386(10003):1546–55. doi: 10.1016/S0140-6736(15)61412-X
  12. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2022. 340 с.
  13. [On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2021: State Report]. Moscow: Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, 2022. 340 p. (In Russ.).
  14. Эпидемиологический надзор за гепатитом В: Методические указания. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора, 2011. 47 с.
  15. [Epidemiological surveillance of hepatitis B: Guidelines]. M., 2011. 47 p. (In Russ.).
  16. Ноздрачева А.В., Асатрян М.Н., Рыбак Л.А., Волошкин А.А., Семененко А.В. Совершенствование эпидемиологической диагностики в системе надзора за корью при помощи новых методов информационнго обеспечения. Эпидемиол. инфекц. болезни. Актуал. вопр. 2022; 12(2): 12–9. doi: 10.18565/epidem.2022.12.2.12–9
  17. Nozdracheva A.V., Asatryan M.N., Rybak L.A., Voloshkin A.A., Semenenko A.V. [Improvement of epidemiological diagnostics in the measles surveillance system using new methods of information support]. Epidemiology and infectious diseases. Current issues 2022; 12(2): 12–9. (In Russ.). doi: 10.18565/epidem.2022.12.2.12–9
  18. Семененко Т.А., Акимкин В.Г. Сероэпидемиологические исследования в системе надзора за вакциноуправляемыми инфекциями. Журнал микробиологии, эпидемиологии и иммунобиологии 2018; (2): 87–94. doi: 10.36233/0372-9311-2018-2-87-94
  19. Semenenko T.A., Akimkin V.G. [Seroepidemiology in the surveillance of vaccine-preventable diseases]. Journal of microbiology, epidemiology and immunobiology 2018; 95(2): 87–94. (In Russ.). doi: 10.36233/0372-9311-2018-2-87-94
  20. Ноздрачева А.В., Гапоненко Е.В., Рыбак Л.А., Семененко А.В. Биобанк как основа обеспечения современных биомедицинских исследований. В кн.: Контроль и профилактика инфекций, связанных с оказанием медицинской помощи (ИСМП-2021). Сборник тезисов IX Конгресса с международным участием. М., 2021: 82–3.
  21. Nozdracheva A.V., Gaponenko E.V., Rybak L.A., Semenenko A.V. [Biobank as a basis for modern biomedical research. In: Control and prevention of infections associated with the provision of medical care (ISMP-2021)]. Collection of abstracts of the IX Congress with international participation. Moscow, 2021: 82–3. (In Russ.).
  22. Анисимов С.В., Ахмеров Т.М., Балановский О.П., Баранич Т.И., Беляев В.Е., Борисова А.Л. и др. Биобанкирование: Национальное руководство. М.: ООО «Издательство ТРИУМФ». М., 2022. 308 с.
  23. Anisimov S.V., Akhmerov T.M., Balanovsky O.P., Baranich T.I., Belyaev V.E., Borisova A.L. et al. [Biobanking: National leadership]. Moscow: TRIUMPH, 2022. 308 p. (In Russ.).
  24. Leung N. Chronic hepatitis B in Asian women of childbearing age. Hepatol. Int. 2009; 3 .(Suppl 1): 24–31. doi: 10.1007/s12072-009-9142-1
  25. Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J., Tita A.T., Silverman N.S. et al. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am. J. Obstet. Gynecol. 2016; 214(1): 6–14. doi: 10.1016/j.ajog.2015.09.100
  26. Профилактика инфекционных болезней. Эпидемиологический надзор за гепатитом B: Методические указания МУ 3.1.2792-10. М., 2010.
  27. [Prevention of infectious diseases. Epidemiological surveillance of hepatitis B]: Methodological guidelines MU 3.1.2792-10. Moscow: 2010. (In Russ.).
  28. Горячева Л.Г., Шилова И.В., Харит С.М. Течение хронического гепатита В у детей, рожденных от матерей с НВ-вирусной инфекцией. Детские инфекции 2015; 14(2): 22–5. https://doi.org/10.22627/2072-8107-2015-14-2-22-25
  29. Goriacheva L.G., Shilova I.V., Kharit S.M. [The course of chronic hepatitis B in infants born to mothers with HBV-infection]. Children infections 2015; 14(2): 22–5. (In Russ.). https://doi.org/10.22627/2072-8107-2015-14-2-22-25
  30. Акимкин В.Г., Семененко Т.А., Никитина Г.Ю., Годков М.А., Скворцов С.В. Эпидемиология гепатитов В и С в лечебно-профилактических учреждениях М.: ООО «Издательский дом «Бионика», 2013. 216 с.
  31. Akimkin V.G., Semenenko T.A., Nikitina G.Yu., Godkov M.A.,. Skvortsov S.V. [Epidemiology of hepatitis B and C in medical and preventive institutions]. Moscow: Bionika, 2013. 216 p. (In Russ.).
  32. Семененко Т.А., Ярош Л.В., Баженов А.И., Никитина Г.Ю., Клейменов Д.А., Эльгорт Д.А. и др. Эпидемиологическая оценка распространенности «скрытых» форм и HBsAg-мутантов вируса гепатита В у гематологических больных. Эпидемиология и вакцинопрофилактика 2012; 6 (67): 9–14.
  33. Semenenko T.A., Yarosh L.V., Bazhenov A.I., Nikitina G.Yu., Kleimenov D.A., Elgort D.A. et al. [Epidemiological assessment of the prevalence of «hidden» forms and HBsAg mutants of hepatitis B virus in hematological patients]. Epidemiology and Vaccinal Prevention 2012; 6(67): 9–14. (In Russ.).
  34. Семененко Т.А. Иммунный ответ при вакцинации против гепатита В у лиц с иммунодефицитными состояниями. Эпидемиология и вакцинопрофилактика 2011; 1(56): 51–8.
  35. Semenenko T.A. [Immune response during vaccination against hepatitis B in persons with immunodeficiency conditions]. Epidemiology and Vaccinal Prevention 2011; 1(56): 51–8. (In Russ.).
  36. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Ding-Shinn Chen, M. et al. [Statements from the Taormina expert meeting on occult hepatitis B virus infection]. J. Hepatol. 2008; 49: 652–7. doi: 10.1016/j.jhep.2008.07.014.22.
  37. Железнякова И.А., Пирова Г.И., Прохорович Е.А. Регистры пациентов и реестры счетов по ОМС: вопросы интеграции и взаимозаменяемости. Современная фармакоэкономика и фармакоэпидемиология 2018; 11(4): 067–072. doi: 10.17749/2070-4909.2018.11.4.067-072
  38. Zheleznyakova I.A., Petrova G.I., Prokhorovich E.A. [Patient registers and registers of CHI accounts: issues of integration and interchangeability]. Modern pharmacoeconomics and pharmacoepidemiology 2018; 11(4): 067–072. (In Russ.). doi: 10.17749/2070-4909.2018.11.4.067-072)

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2024